Dr. Jitendra Singh inaugurates 54th RSSDI Annual Conference in Bengaluru
Synopsis
Key Takeaways
India's diabetes research community gathered in Bengaluru on Friday, November 20, 2026, as Union Science and Technology Minister Dr. Jitendra Singh lit the traditional lamp to inaugurate the 54th Annual Conference of the Research Society for the Study of Diabetes in India (RSSDI) — a four-day conclave that brings together the country's foremost clinicians, researchers, and public-health professionals under one roof.
The lamp-lighting ceremony, steeped in the academic tradition of Indian scientific gatherings, was described by Dr. Singh as symbolising 'the spirit of knowledge, learning and collective commitment towards advancing diabetes research and care.' For a nation carrying one of the heaviest diabetes burdens on the planet, the symbolism lands with particular weight.
Why RSSDI's annual forum matters for India's diabetes crisis
India is home to an estimated 100 million-plus diabetics — a figure that places it among the top two nations globally by absolute case count. The Research Society for the Study of Diabetes in India has, over five decades, evolved from a niche professional body into a primary national platform where clinical guidelines are debated, research findings are stress-tested, and care protocols are updated. Its annual conference is where that intellectual churn happens in real time.
Ministerial presence at the 54th edition is not incidental. It signals continued high-level attention to non-communicable diseases at a moment when India's public-health architecture is being stress-tested by a double burden: communicable diseases on one side, a surging NCD tide on the other.
NPCDCS and the policy scaffolding behind the science
The government's formal commitment to diabetes control dates at least to 2010, when India launched the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS). That programme created a nationwide screening and management infrastructure, but researchers at forums like RSSDI have consistently argued that implementation gaps — especially in primary care settings — remain the defining challenge. The conference provides a live feedback loop between frontline science and policy.
Dr. Singh's portfolio spans Science and Technology and Earth Sciences, making his appearance a cross-sectoral signal: advances in diagnostics, genomics, and data-driven health tools increasingly sit at the intersection of science policy and medical care.
Four days of deliberations lie ahead. What emerges from the research presentations and clinical debates in Bengaluru this week could quietly shape the next iteration of India's diabetes management guidelines — and that is exactly why the lamp was worth lighting.